INSERM (Institut National de la Santé et de la Recherche Médicale);Institut Jean Godinot;Université Paris Diderot - Paris 7;Assistance Publique-Hôpitaux de Paris (APHP)
发明人:
Bensussan, Armand,Bagot, Martine,Giustiniani, Jérôme,Merrouche, Yacine,De Masson, Adèle,Marie-Cardine, Anne
申请号：
AU2016289493
公开号：
AU2016289493A1
申请日:
2016.07.07
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present disclosure relates to methods and pharmaceutical compositions for enhancing NK cell killing activities. In particular, the disclosure relates to a method of enhancing NK cell killing activities in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a compound capable of stimulating CD245 on NK cells.
